← Eichor
Condition: Tissue Donors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tissue Donors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
Phase 2 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07635056NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Phase 2 · 13 location(s) · New Approaches to Neuroblastoma Therapy Consortium · NCT06450041HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Ste
Phase 1 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03326921A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherap
Phase 1/Phase 2 · 22 location(s) · Nationwide Children's Hospital · NCT05634369Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT05628974The Effectiveness of Nano Bio Fusion Gingival Gel (NBF) on Wound Healing at the Palate (Donor Site) After Soft Tissue Gr
NA · 1 location(s) · King Abdullah University Hospital · NCT07330154Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001529Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · 10 location(s) · Fred Hutchinson Cancer Center · NCT03779854Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Phase 2 · 3 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT01804634Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE
Phase 2 · 4 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06919003Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to
Phase 1/Phase 2 · 1 location(s) · Kari Kendra · NCT05588453Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
Phase 2 · 25 location(s) · Medical College of Wisconsin · NCT06517641Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From
Phase 1/Phase 2 · 1 location(s) · Alice Bertaina · NCT05508009Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410494Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
NA · 1 location(s) · Virginia Commonwealth University · NCT06892496NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Phase 1/Phase 2 · 1 location(s) · Nationwide Children's Hospital · NCT04211675Donor Site Morbidity After Free Vascularized Fibular Graft
Phase N/A · 1 location(s) · Assiut University · NCT06324916Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03000244Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT04003038PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510828ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
Phase 2 · 12 location(s) · Massachusetts Eye and Ear Infirmary · NCT06753916Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue
Phase 2 · 1 location(s) · Choon Hyuck David Kwon · NCT07102550Effect of Cyanoacrylate Tissue Adhesive Versus Collagen Sponge on Palatal Donor Site Healing
EARLY_Phase 1 · 1 location(s) · Beirut Arab University · NCT07086482Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus H
Phase 2/Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07366801Non-invasive Preoperative Tissue Evaluation in Head and Neck Tumor Patients Using Multispectral Optoacoustic Tomography
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT06716892Analysis of the Reliability and Validity of Laser Speckle Contrast Imaging
NA · 1 location(s) · Universidad Complutense de Madrid · NCT07527351A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Disease
Phase 1 · 28 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT07115745
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.